Nathan Fischer
Bloomfield, CTNPI 1932291523
Payments from drug & device makers
What this record shows
This record is dominated by royalties or licence payments: $568,280 of the $568,280 with a category attached, or 100.0%. Every reported general payment came from a single manufacturer, Coopersurgical, Inc.. Reporting peaked in 2024 at $146,861 and has fallen 66.3% since, to $49,456 in 2025.
Across 32 payments — averaging $17,759 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Coopersurgical, Inc.$568K
What the payments were for
- Royalty or licence$568,280100%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Coopersurgical, Inc. | 32 | $568,280 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Wallach$260,784
- LEEP Product Line$258,039
- WALLACH Cryosurgical Equipment$49,456
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.